325 related articles for article (PubMed ID: 37383719)
1. Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural compounds.
Li Y; Zhang C; Feng L; Shen Q; Liu F; Jiang X; Pang B
Front Pharmacol; 2023; 14():1195104. PubMed ID: 37383719
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
Peng H; He X; Wang Q
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):941-951. PubMed ID: 35751489
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
4. Role of CC-chemokine ligand 2 in gynecological cancer.
Zhang JJ; Liu W; Xing GZ; Xiang L; Zheng WM; Ma ZL
Cancer Cell Int; 2022 Nov; 22(1):361. PubMed ID: 36403055
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
6. Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
Lee SM; Lee S; Cho HW; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674491
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the prognostic value and immune function of the
Zhou Q; Cao FH; Liu H; Zuo MZ
Am J Transl Res; 2021; 13(4):2041-2059. PubMed ID: 34017374
[TBL] [Abstract][Full Text] [Related]
8. Application of Extracellular Vesicles in Gynecologic Cancer Treatment.
Zhang R; Zou Y; Luo J
Bioengineering (Basel); 2022 Nov; 9(12):. PubMed ID: 36550946
[TBL] [Abstract][Full Text] [Related]
9. Challenges associated with the management of gynecological cancers in a tertiary hospital in South East Nigeria.
Iyoke CA; Ugwu GO; Ezugwu EC; Ezugwu FO; Lawani OL; Onyebuchi AK
Int J Womens Health; 2014; 6():123-30. PubMed ID: 24493933
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms.
Pourhanifeh MH; Farrokhi-Kebria H; Mostanadi P; Farkhondeh T; Samarghandian S
Curr Mol Pharmacol; 2024; 17():e18761429263063. PubMed ID: 38284731
[TBL] [Abstract][Full Text] [Related]
11. Role of the RNA-binding protein family in gynecologic cancers.
Hao L; Zhang J; Liu Z; Zhang Z; Mao T; Guo J
Am J Cancer Res; 2023; 13(8):3799-3821. PubMed ID: 37693158
[TBL] [Abstract][Full Text] [Related]
12. Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.
Moss CL; Guerrero-Urbano T; White I; Taylor B; Kristeleit R; Montes A; Fox L; Beyer K; Sztankay M; Ratti MM; Sisca ES; Derevianko A; MacLennan S; Wood N; Wintner LM; Van Hemelrijck M
Future Oncol; 2023 Mar; 19(9):663-678. PubMed ID: 37128990
[TBL] [Abstract][Full Text] [Related]
13. Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
Su SY
Prev Med; 2023 Jul; 172():107551. PubMed ID: 37211252
[TBL] [Abstract][Full Text] [Related]
14. Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors.
Lainé A; Gonzalez-Lopez AM; Hasan U; Ohkuma R; Ray-Coquard I
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046702
[TBL] [Abstract][Full Text] [Related]
15. Unraveling role of ubiquitination in drug resistance of gynecological cancer.
Yu L; Chen Z; Wu Y; Xu M; Zhong D; Xu H; Zhu W
Am J Cancer Res; 2024; 14(5):2523-2537. PubMed ID: 38859858
[TBL] [Abstract][Full Text] [Related]
16. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of Curcuma oil and its terpenoids in gynecological cancers.
Zhang Y; Peng F; Yu C
Biomed Pharmacother; 2023 Jan; 157():114016. PubMed ID: 36395609
[TBL] [Abstract][Full Text] [Related]
18. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis.
Zhang N; Liu C; Di W
Onco Targets Ther; 2023; 16():545-558. PubMed ID: 37448551
[TBL] [Abstract][Full Text] [Related]
19. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
